RecallHawk
Class III Recall

Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot K

Fagron, Inc

Summary

The FDA issued a Class III for Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescriptio by Fagron, Inc. Reason: Subpotent Drug.

Details

Source

Drug Recall

External ID

D-0863-2022

Action Date

2022-05-18

Status

Terminated

Category

drug

Product Description

Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot Knob Rd., St Paul, MN 55120. NDC 51552-1564-05

Lot/Code Info: Lot #: 18H02-U02-044978, 18L12-U02-050018, Exp. Date 10/31/2022 18L12-U02-000952, Exp. Date Sep 2023

Quantity Affected: 53 containers

Reason for Recall

Subpotent Drug

Distribution

Nationwide within the USA

Type: Voluntary: Firm initiated

Recall Initiated: 2022-03-04

Company

Fagron, Inc

Saint Paul, MN

Context & Analysis

This is a Class III recall. Class III recalls involve products unlikely to cause adverse health consequences, but that violate FDA regulations.

This was one of 43 drug recalls issued in the same week, part of 267 drug-related FDA actions this month.

Fagron, Inc has 10 FDA actions in our database, including 10 recalls.

Frequently Asked Questions

What is a Class III recall?

A Class III recall involves products that are unlikely to cause adverse health effects but violate FDA labeling or manufacturing regulations.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Fagron, Inc) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Fagron, Inc have FDA actions?

Fagron, Inc has 10 FDA actions in our database, including 10 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "D-0863-2022" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions